[{"orgOrder":0,"company":"Neupharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ITALY","productType":"Antibiotic","year":"2021","type":"Inapplicable","leadProduct":"Teicoplanin","moa":"Peptidoglycan","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Neupharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Aerosol","sponsorNew":"Neupharma \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Neupharma \/ Undisclosed"},{"orgOrder":0,"company":"Neupharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ITALY","productType":"Antibiotic","year":"2020","type":"Inapplicable","leadProduct":"Teicoplanin","moa":"Peptidoglycan","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Neupharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Aerosol","sponsorNew":"Neupharma \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Neupharma \/ Undisclosed"},{"orgOrder":0,"company":"Neupharma","sponsor":"Sintesi Research Srl | Evotec | Pari","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"ITALY","productType":"Antibiotic","year":"2019","type":"Inapplicable","leadProduct":"Teicoplanin","moa":"Peptidoglycan","graph1":"Genetic Disease","graph2":"Phase I","graph3":"Neupharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Inhalation","sponsorNew":"Neupharma \/ Sintesi Research Srl | Evotec | Pari","highestDevelopmentStatusID":"6","companyTruncated":"Neupharma \/ Sintesi Research Srl | Evotec | Pari"},{"orgOrder":0,"company":"Neupharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"ITALY","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"RX108","moa":"Sodium\/potassium-transporting ATPase (SPT ATPase)","graph1":"Oncology","graph2":"Phase I","graph3":"Neupharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Neupharma \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Neupharma \/ Undisclosed"}]